Limited Breadth of a T-Helper Cell Response to a Human Immunodeficiency Virus Envelope Protein
- 1 April 2003
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 77 (7) , 4231-4236
- https://doi.org/10.1128/jvi.77.7.4231-4236.2003
Abstract
Single-envelope human immunodeficiency virus (HIV) vaccines have been studied for more than a decade, with some successes in homologous challenge experiments in nonhuman primates but with no clear successes in clinical trials. To gain insight into the breadth of the immunity elicited by such vaccines, we have dissected the T-helper cell response of C57BL/6 mice to an individual, molecularly cloned envelope protein. Here, we report that T-helper cells responsive to HIV type 1 1035 envelope are very highly restricted in C57BL/6 animals: seven different hybridomas recovered from five separate mice recognized the same peptide, PKVSFEPIPIHYCAP, located in the C2 region of gp120. Three of these hybridomas were tested on a natural variant of the peptide but failed to respond. A more extensive analysis of whole splenic populations from other C57BL/6 mice immunized with the 1035 envelope reproducibly confirmed that the gp120-specific T-helper response was almost exclusively focused on a single epitope. We conclude that single-envelope vaccines may frequently fail to provoke an immune response sufficiently diverse to recognize variant sequences among circulating HIV. The results encourage the inclusion of more than one envelope in future vaccines to enhance the potential diversity and respective surveillance capacities of responding T-helper cell populations.Keywords
This publication has 39 references indexed in Scilit:
- Comprehensive Screening for Human Immunodeficiency Virus Type 1 Subtype-Specific CD8 Cytotoxic T Lymphocytes and Definition of Degenerate Epitopes Restricted by HLA-A0207 and -CW0304 AllelesJournal of Virology, 2002
- Structural Basis for Helper T-cell and Antibody Epitope Immunodominance in Bacteriophage T4 Hsp10Journal of Biological Chemistry, 2002
- Allocation of Helper T-cell Epitope Immunodominance According to Three-dimensional Structure in the Human Immunodeficiency Virus Type I Envelope Glycoprotein gp120Journal of Biological Chemistry, 2001
- T lymphocyte responses in HIV-1 infection: implications for vaccine developmentCurrent Opinion in Immunology, 1999
- Human Immunodeficiency Virus Glycoprotein-Specific CD4+Cytotoxic T Lymphocytes Are Involved in Two Types of Cytotoxicity: Antigen-Specific and Cell-Cell Fusion-Related Cell LysisAIDS Research and Human Retroviruses, 1997
- Eliciting HIV-1 envelope-specific antibodies with mixed vaccinia virus recombinantsVaccine, 1997
- Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials NetworkJAMA, 1994
- Identification of T-cell epitopes without B-cell activity in the first and second conserved regions of the HIV Env proteinAIDS, 1991
- Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160Nature, 1990
- Requirement for Cotolerogenic Gene Products in the Clonal Deletion of I-E Reactive T CellsScience, 1990